Latest News

October 19, 2000
Four scientific leaders at the University of California, San Francisco—a pioneer in molecular studies related to cancer and aging, an international leader in HIV prevention research and policy issues, an expert on oral manifestations of AIDS, and a distinguished advocate for improving pharmacy education and practice—have been elected to the prestigious Institute of Medicine.
October 19, 2000
A University of California, San Francisco biochemist and colleagues have revealed the atom-by-atom structure of an ancient and extremely discriminating kind of channel embedded in cell membranes, from bacteria to humans.
October 18, 2000
Group appointments are a feasible way to deliver care to chronically ill, low-income women, a UCSF study has found. In this pilot study, a family physician and family nurse practitioner team guided six 90-minute appointments for patient groups as large as 15.
October 16, 2000
Beginning Monday October 16, The Glide Health Clinic will expand its services to include a special clinic session that will offer complementary care therapies to the homeless and disenfranchised of San Francisco’s Tenderloin District.
October 16, 2000
UCSF Comprehensive Cancer Center basic scientists and clinical researchers have received a highly coveted grant from the National Cancer Institute that they say will fuel their ongoing mission to methodically and aggressively move in on prostate cancer.
October 10, 2000
A recent study of San Francisco Bay Area physicians reports on successful intervention techniques for victims of domestic violence.
October 05, 2000
A team of scientists at the University of California, San Francisco and Compugen, Ltd. has discovered a new molecule of the immune system -- a member of a family of proteins called chemokines which recruit the body's army of defensive immune cells to sites of invasion.
October 04, 2000
The UCSF Comprehensive Cancer Center is enrolling patients for three clinical trials to investigate a new treatment for kidney cancer, prostate cancer and melanoma. The trials aim is to determine if early immune cells, called stem cells, can be collected and transferred from a patient’s sibling into the patient to attack the cancer.
October 03, 2000
The University of California, San Francisco Audiology Clinic will launch new research in October to study the world’s first disposable hearing aids, costing about $40 and lasting approximately 40 days.
October 01, 2000
University of California San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx-015 works more broadly than had been expected...